Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOBUNOLOL vs LEVOMEPROMAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOBUNOLOL vs LEVOMEPROMAZINE: Safety Overview

Metric LEVOBUNOLOL LEVOMEPROMAZINE
Total FAERS Reports 144 3,024
Deaths Reported 2 585
Death Rate 1.4% 19.3%
Hospitalizations 7 1,564
Average Patient Age 76.5 yrs 44.1 yrs
% Female Patients 65.8% 47.2%
FDA Approval Date Aug 3, 2000 Approved Prior to Jan 1, 1982
Manufacturer Bausch & Lomb Incorporated N/A
Route OPHTHALMIC N/A
Marketing Status Prescription Discontinued